Loading...
XSHG603882
Market cap1.61bUSD
Jan 15, Last price  
25.72CNY
1D
-0.89%
1Q
-30.15%
IPO
134.24%
Name

Guangzhou Kingmed Diagnostics Group Co Ltd

Chart & Performance

D1W1MN
XSHG:603882 chart
P/E
18.30
P/S
1.38
EPS
1.41
Div Yield, %
7.13%
Shrs. gr., 5y
0.38%
Rev. gr., 5y
13.54%
Revenues
8.54b
-44.82%
977,201,9701,356,070,8811,837,857,6912,389,392,2213,221,579,7223,791,717,6834,525,252,8285,269,266,4978,243,763,51611,943,223,63015,476,074,5388,539,627,901
Net income
643m
-76.64%
44,085,46052,447,02931,255,951131,430,840170,035,207188,505,401233,321,406402,331,1271,509,701,8872,219,640,4452,754,787,044643,382,149
CFO
1.23b
-36.81%
88,437,50075,549,100225,966,983220,388,055292,141,284283,534,715529,623,040661,396,1591,523,107,5662,087,970,5901,947,842,7381,230,820,619
Dividend
Jun 18, 20240.88 CNY/sh
Earnings
May 20, 2025

Profile

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial intelligence, and forensic testing services. It operates 37 testing laboratories in mainland of China and Hong Kong. The company was founded in 2003 and is headquartered in Guangzhou, China.
URL
http://www.kingmed.com.cn/
IPO date
Sep 08, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,539,628
-44.82%
15,476,075
29.58%
Cost of revenue
7,573,146
11,336,606
Unusual Expense (Income)
NOPBT
966,482
4,139,468
NOPBT Margin
11.32%
26.75%
Operating Taxes
103,380
477,746
Tax Rate
10.70%
11.54%
NOPAT
863,102
3,661,723
Net income
643,382
-76.64%
2,754,787
24.11%
Dividends
(839,332)
(596,213)
Dividend yield
2.88%
1.63%
Proceeds from repurchase of equity
(89,995)
BB yield
0.31%
Debt
Debt current
1,000
221,665
Long-term debt
628,128
550,262
Deferred revenue
24,421
Other long-term liabilities
24,972
1
Net debt
(2,412,228)
(2,534,264)
Cash flow
Cash from operating activities
1,230,821
1,947,843
CAPEX
(714,746)
Cash from investing activities
(634,763)
Cash from financing activities
FCF
1,001,783
1,791,569
Balance
Cash
2,457,663
2,928,686
Long term investments
583,693
377,506
Excess cash
2,614,374
2,532,388
Stockholders' equity
6,862,139
7,542,843
Invested Capital
6,406,860
6,683,477
ROIC
13.19%
66.75%
ROCE
10.64%
44.61%
EV
Common stock shares outstanding
466,219
467,366
Price
62.41
-20.19%
78.20
-29.78%
Market cap
29,096,725
-20.39%
36,548,014
-29.62%
EV
26,869,054
34,257,122
EBITDA
1,645,053
4,667,871
EV/EBITDA
16.33
7.34
Interest
20,391
23,653
Interest/NOPBT
2.11%
0.57%